[1]吴奇俊,张东梅,翟志芳,等.狼疮性肾炎不同病理分型的疾病活动性及终末期肾病的危险因素分析[J].第三军医大学学报,2020,42(23):2336-2340.
 WU Qijun,ZHANG Dongmei,ZHAI Zhifang,et al.Disease activity of lupus nephritis with different pathological types and risk factors of end-stage renal disease: analysis of 305 cases [J].J Third Mil Med Univ,2020,42(23):2336-2340.
点击复制

狼疮性肾炎不同病理分型的疾病活动性及终末期肾病的危险因素分析(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
42卷
期数:
2020年第23期
页码:
2336-2340
栏目:
临床医学
出版日期:
2020-12-15

文章信息/Info

Title:
Disease activity of lupus nephritis with different pathological types and risk factors of end-stage renal disease: analysis of 305 cases 
作者:
吴奇俊张东梅翟志芳宋志强
陆军军医大学(第三军医大学)第一附属医院皮肤科
Author(s):
WU Qijun ZHANG Dongmei ZHAI Zhifang SONG Zhiqiang

Department of Dermatology, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China

关键词:
狼疮性肾炎临床表现病理分型终末期肾脏病危险因素
Keywords:
lupus nephritis clinical features pathological types end-stage renal disease risk factor
分类号:
R181.32; R446.8; R593.242
文献标志码:
A
摘要:

目的分析狼疮性肾炎(lupus nephritis,LN)患者不同病理分型与临床疾病活动性和预后的关系,以及终末期肾病(end-stage renal disease, ESRD)的危险因素。方法回顾性分析本院2013-2018年经肾活检确诊的305例LN患者,按肾脏病理分为毛细血管内细胞增多性LN(包括LN-Ⅲ/Ⅳ146例、合并膜性病变的LN-Ⅲ/Ⅳ+Ⅴ106例)和非毛细血管内细胞增多性LN(LN-Ⅱ/Ⅴ53例),比较不同病理分型患者的疾病活动性和预后的差异,通过回归分析探索ESRD的危险因素。结果与LN-Ⅱ/Ⅴ相比,LN-Ⅲ/Ⅳ(伴或不伴LN-Ⅴ)患者SLEDAI评分≥10分比例更高(66.3% vs 45.3%),且出现浆膜炎、脱发、贫血、血肌酐增高、血尿、ESRD以及抗ds-DNA、AnuA抗体阳性的比例均更高(P<0.05)。ESRD整体累积发病率为14.4%,LN-Ⅲ/Ⅳ(伴或不伴LN-Ⅴ)是ESRD的独立危险因素(OR值为2.977),此外,抗dsDNA抗体阳性、血肌酐增高、SLEDAI评分≥10分亦为ESRD的独立危险因素(OR值分别为1.722、5.484、2.070)。不同病理类型患者的生存时间分布差异无统计学意义(P>0.05)。结论LN-Ⅲ/Ⅳ(伴或不伴LN-Ⅴ)型患者表现出更高的疾病活动性,肾脏和肾外损害更重,进展为ESRD的风险更高。

Abstract:

ObjectiveTo explore the relationship of lupus nephritis (LN) with different pathological types with disease activity and prognosis, and investigate the risk factors of end-stage renal disease (ESRD). MethodsA total of 305 pathologically-confirmed LN patients admitted in our hospital from the year of 2013 to 2018 were retrospectively enrolled in this study. According to the results of renal biopsy, they were divided into mesangial hypercellularity LN (including 146 cases of LN-Ⅲ/Ⅳ and 106 cases of LN-Ⅲ/Ⅳ+Ⅴ) and non-mesangial hypercellularity LN (53 cases of LN-Ⅱ/Ⅴ). The disease activity and prognosis of the patients with different pathological types were compared, and the risk factors of ESRD were explored. ResultsThere were more patients with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) ≥10 (66.3% vs 45.3%), occurrences of serositis, hair loss, anemia, higher serum creatinine, hematuria, and ESRD, and manifestations of anti-dsDNA antibody and anti-AnuA antibody in the LN-Ⅲ/Ⅳ patients (with or without LN-Ⅴ) than the LN-Ⅱ/Ⅴ patients (P<0.05). The cumulative incidence of ESRD was 14.4%, and LN-Ⅲ/Ⅳ(with or without LN-Ⅴ), as well as anti-dsDNA antibody, higher serum creatinine, and SLEDAI ≥10, was identified as independent risk factors for ESRD (OR=2.977, 1.722, 5.484, 2.070). But there was no statistical difference in survival time among different pathological types (P>0.05). ConclusionThe LN-Ⅲ/Ⅳ patients (with or without LN-Ⅴ) have higher disease activity, severer impairment both in inside and outside of the kidney, and higher risk of progression to ESRD. 

相似文献/References:

[1]胡梅,秦新月,李咏梅.以发作性构音障碍为首发症状的多发性硬化1例[J].第三军医大学学报,2007,29(05):465.
[2]杨超,刘星,余星,等.103例儿童睾丸扭转的临床表现及诊治[J].第三军医大学学报,2010,32(14):1568.
[3]项平,周鋆,方颖,等.老年溃疡性结肠炎患者的临床、内镜和病理分析[J].第三军医大学学报,2009,31(16):1542.
 XIANG Ping,ZHOU Jun,FANG Ying,et al.Analysis of the clinical, endoscopic and pathological features between the aged and non-aged patients with ulcerative colitis[J].J Third Mil Med Univ,2009,31(23):1542.
[4]陈爱平,黄光武,苏纪平.10例原发性气管肿瘤临床分析[J].第三军医大学学报,2011,33(11):1201.
[5]罗晓南,刘凤,江荣.54例川崎病患者早期识别与诊断的临床分析[J].第三军医大学学报,2012,34(14):1396.
[6]成戎川,李黔宁,刘勇,等.6例急性四乙基铅中毒临床表现分析[J].第三军医大学学报,2004,26(11):0.[doi:10.16016/j.1000-5404.2004.11.015 ]
[7]张敬如,王英,杨松,等.三峡库区肺吸虫病临床表现和误诊原因分析[J].第三军医大学学报,2003,25(12):0.[doi:10.16016/j.1000-5404.2003.12.017 ]
[8]尹锐,刁庆春,王鲁,等.伴嗜酸性粒细胞增多性血管淋巴样增生的临床病理分析[J].第三军医大学学报,2001,23(04):0.[doi:10.16016/j.1000-5404.2001.04.057 ]
 YIN Rui,DIAO Qing-chun,WANG Lu,et al.[J].J Third Mil Med Univ,2001,23(23):0.[doi:10.16016/j.1000-5404.2001.04.057 ]

更新日期/Last Update: 2020-12-04